Evidence map›Paper›PMID 30562927›Full record

ArticleInternational journal of molecular sciences2018

Neuromuscular Junction Changes in a Mouse Model of Charcot-Marie-Tooth Disease Type 4C.

Silvia Cipriani, Vietxuan Phan, Jean-Jacques Médard, Rita Horvath, Hanns Lochmüller, Roman Chrast, Andreas Roos, Sally Spendiff

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Junctions in Jeopardy: the neuromuscular junction is a selective pathological target in Charcot-Marie-Tooth disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Charcot-Marie-Tooth disease type 4C associated with myasthenia gravis: coincidental or a foreseeable association?Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  12. Review
  13. Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 6 countries.

Silvia CiprianiJohn Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK. cipriani.silvia@hsr.it.
Vietxuan PhanLeibniz-Institut für Analytische Wissenschaften -ISAS- e.V.; Otto-Hahn-Strasse 6b, 44227 Dortmund, Germany. vietxuan.phan@gmail.com.
Jean-Jacques MédardDepartment of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden. jean-jacques.medard@ki.se.
Rita HorvathDepartment of Clinical Neurosciences, University of Cambridge, John Van Geest Cambridge Centre for Brain Repair, Forvie, Robinson way, Cambridge Biomedical Campus, Cambridge CB2 0PY, UK. rh732@medschl.cam.ac.uk.
Hanns LochmüllerDepartment of Neuropediatrics and Muscle Disorders, Medical Center-University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany. hlochmuller@cheo.on.ca.ORCID 0000-0003-2324-8001
Roman ChrastDepartment of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden. roman.chrast@ki.se.
Andreas RoosLeibniz-Institut für Analytische Wissenschaften -ISAS- e.V.; Otto-Hahn-Strasse 6b, 44227 Dortmund, Germany. andreas.roos@isas.de.ORCID 0000-0003-2833-0928
Sally SpendiffJohn Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK. sspendiff@cheo.on.ca.
Karolinska Institutet · SEUniversity of Ottawa · CAEssen University Hospital · DELeibniz Institute for Analytical Sciences - ISAS · DESan Raffaele University of Rome · ITUniversity of Cambridge · GB

Funding

Association Française contre les Myopathies 21644Medical Research Council G1000848Medical Research Council MR/N010035/1Medical Research Council MR/N025431/1Medical Research Council MR/N025431/2Wellcome Trust 201064/Z/16/Z
6 · The paper itself

Abstract

The neuromuscular junction (NMJ) appears to be a site of pathology in a number of peripheral nerve diseases. Charcot-Marie-Tooth (CMT) 4C is an autosomal recessive, early onset, demyelinating neuropathy. Numerous mutations in the

Indexed as

Carrier ProteinsCharcot-Marie-Tooth DiseaseMuscle, SkeletalMutationNeuromuscular JunctionSciatic NerveAnimalsDisease Models, AnimalExonsGene Knockdown TechniquesIntracellular Signaling Peptides and ProteinsMiceMice, Mutant StrainsCarrier ProteinsIntracellular Signaling Peptides and ProteinsSh3tc2 protein, mouseCharcot-Marie-Tooth disease 4Cdemyelinationmouse modelsneuromuscular junctionperipheral neuropathySH3TC2

Identifiers

PMID30562927
PMCPMC6320960
OpenAlexW2904333943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.